I have to say that I am not looking forward to the White

New Post Public Reply Private Reply Replies (6) Message Board
TechGuru
1,016
I have to say that I am not looking forward to the White House’s announcement of a "major therapeutic breakthrough" on coronavirus.

I really don’t want to go into politics. We all have different points of view and this board is about investment on CYDY. But, as this announcement is probably going to be made by POTUS is political in nature.

Why I don’t like it ??? Well, the RNC convention starts today. The polls are currently negative for POTUS, all this re-enforced by the disastrous management of the COVID crisis in the USA.

All eyes are tuned to the convention and the best pre-strike is a BIG announcement on COVID and this is precisely what will be happening.

Timing says it all.

The question is: is this science based ?? Is the truth ?? Or, if you wish: is the truth ready to be told?? Or, for us: have clinical trials been concluded for this particular “breakthrough” and it is scientifically sound ???

It depends. However, referring to COVID this gives you pause, these are twits from POTUS:

Quote:
Obviously, they are hoping to delay the answer until after November 3rd,” Trump tweeted, referring to Election Day. “Must focus on speed, and saving lives!


And:

Quote:
The deep state, or whoever, over at the FDA is making it very difficult for drug companies to get people in order to test the vaccines and therapeutics. Obviously, they are hoping to delay the answer until after November 3rd. Must focus on speed, and saving lives!


Would suggest that FDA will be somewhat bypassed by the announcement.
I am not a friend of FDA (for reasons completely different not related to the state but BP), but one cannot just throw the baby with the bath water.

So, which drug will be announced??. Well, one would normally go directly and check which ones have statistical data, or are about to have statistical data in double-blinded trials run by the FDA (as we are talking USA here), some obvious candidates:

Leronlimab (CYDY) . Data from P2 for M2M and ongoing P3 for S2C
Lenzilumab (HGEN). Expecting P3
REGN-EB3 (REGN) In ”adaptive trials” several phases.

However, in this highly and politically charged environment I think the announcement will not be for any drug in which the government cannot claim to have invested amounts of money and used Warp speed and basically “saved the world”.

We did not receive a penny. The White House cannot claim they did anything to get Leronlimab to succeed. Is not a “convenient” therapeutics and is not what the political environment demands. It demands something that can be claimed as a triumph, as good management, as warp speed working, as COVID will be thing of the past yesterday.

This is not us and this is why I don’t like this announcement. A drug that probably is not ready, has not been probably fully tested (as FDA is now “deep state”) will be announced now because is convenient.

To the momentary detriment of the rest of us small companies playing by the rules who will have to wait until the science really confirms or not the drug that will get the “political” spotlight, as opposed to scientific idem.

I think REGN checks all the boxes. Received $450 Million from government, made a deal with Roche for production and the production has been already purchased. They got “adaptive” trials that can be manipulated and terminated before /full enrollment deadlines. And somebody wants them terminated before Nov 3.

Another possibility is to crown Remdesivir in spite of FDA and weak scientific evidence.

I surely hope I am wrong, and don’t want to make this a political post. Just trying to share my thoughts on why we should not feel optimistic about this announcement.
6

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Massimo Debuts 1500 UTV Line at 2026 SEMA Show

Updated Category News Views 110

Setting the Stage at SEMA 2026 In the chaotic whirl of the 2026 SEMA Show, Massimo Group didn't just roll out new wheels—they took a leap into the big leagues. Amidst the bustling Vegas crowd, Massimo unveiled their latest babies: the Warrior 1500XD and the Sentinel 1500 HVAC Crew. These ain't just any UTVs; they're packing some serious muscle with a 1,499cc engine,...

Continue Reading
Cambiotics Launches Key Trial on Reducing PFAS in Firefighters

Updated Category News Views 92

Pioneering Efforts to Combat 'Forever Chemicals' Cambiotics is stepping into some uncharted territory—tackling the tricky problem of PFAS accumulation in firefighters. If you’ve been following this, PFAS, or per- and polyfluoroalkyl substances, have been living rent-free in our bodies for years. Used in firefighting equipment and foams, these chemicals stick around,...

Continue Reading
Metacon Q3 Report Unveiled Amid Green Hydrogen Buzz

Updated Category News Views 43

Peeling Back Metacon's Q3 2026 Figures Alright, let's sink our teeth into the meat and potatoes of Metacon's latest report. The interim report for Q3 2026 hit the newsstands, but it's what's lurking behind the numbers that tells the real story. With all the green energy buzz, Metacon's report is a mixed bag, reflecting their uphill journey in hydrogen pursuits and...

Continue Reading
PrimeBOT: Breaking Tech Molds with Celeb Backing

Updated Category News Views 62

Not Your Average Tech Buzz It starts with Hollywood glitz and an unexpected dance partner. The PrimeBOT, a Chinese personal robot, is ditching the drab tech corner and seeping into mainstream culture. Imagine Johnny Depp slapping some paint on this machine alongside local kids. Now, picture the Kardashians casually dining with it, letting it join their lunchtime...

Continue Reading
ISU and Ares Forge Path in Solid-State Battery Tech

Updated Category News Views 76

Solid-State Dreams Meet AI Magic Ah, the sweet sound of synergy. ISU Specialty Chemical and Ares Materials are brewing up something that could shake the battery world—solid-state cells juiced by AI-driven polymer magic. Now, the tech and finance geeks are likely on the edge of their seats. This isn't just another run-of-the-mill collab; it's a heavyweight match to speed...

Continue Reading
SRG DocketWatch: Tracking FCC Docs in Real-Time

Updated Category News Views 48

I'll admit it—sometimes the FCC moves like molasses uphill. But keeping track of what they're up to? That's where the real challenge lies. Summit Ridge Group has tossed a lifeline for anyone who's got skin in the game with their new service, SRG DocketWatch. Why SRG DocketWatch Hits the Mark If you're poking your head into more than a few of those 21,000 FCC...

Continue Reading
Doximity Faces Class Action: Investor Guidance Needed

Updated Category News Views 54

Doximity Lands in Hot Water: The Stakes for Investors Alright, traders, there's a storm brewing around Doximity (NYSE:DOCS), and it's a doozy. A class action lawsuit has been slapped on this digital platform for medical pros, and the accusations are serious. If you rode the wave and snagged yourself some shares between August 8, 2024, and May 13, 2026, you're right in the...

Continue Reading
Sectra Powers Radiology at Mount Sinai with AI Integration

Updated Category News Views 31

AI and Radiology: A Match Made for Mount Sinai Today, we're diving into a technological leap that promises to shake up the healthcare sector—Sectra's integration of artificial intelligence with radiology at Mount Sinai Health System. The deal pairs Sectra's prowess in medical imaging IT and cybersecurity with the healthcare giant in New York, aiming to redefine how...

Continue Reading
Protein Dynamics: Insights into DNA Maintenance

Updated Category News Views 28

Unlocking the Mechanics of DNA Handling If there's one thing that drives scientific snooping, it's the quest for details as minute as a fly speck on an elephant. Over at Kanazawa University, scientists have peeled back the curtain on an intriguing game of molecular ballet. What they've used to catch this dance in action? High-speed atomic force microscopy, that’s what....

Continue Reading
IGT and MGM Springfield Unveil Jackpot Games in MA

Updated Category News Views 101

Milestone Event in Massachusetts Gaming Scene When IGT and MGM Springfield team up to unveil the first wide-area progressive slots games in Massachusetts, it’s more than just a new game on the floor—it's a seismic shift in the region's gambling landscape. We've got twenty new shiny wheels turning over at the MGM Springfield, with jackpots starting at a hefty $1.125...

Continue Reading

Top 5 Most Recently Viewed Articles

Unveiling the Growth of a $100 Mastercard Investment Over 15 Years

Updated Category News Views 135

Understanding Mastercard's Remarkable Growth Mastercard Inc (NYSE: MA) has shown impressive performance in the financial market, consistently outpacing the overall market by a remarkable margin. Over the past 15 years, the company has achieved an average annual return of 25.57%. This exceptional performance is indicative of the strong fundamentals and strategic business...

Continue Reading
A Deep Dive into Comcast's Position Against Media Rivals

Updated Category News Views 74

Decoding Comcast's Market Strategy In the frenetic whirl of the media industry, you’ve got to keep your head on a swivel—there’s competition at every corner. Comcast (CMCSA) finds itself in this digital gladiatorial arena, vying for attention against other big shots while riding on some impressive wins from previous acquisitions. Operating through three robust...

Continue Reading
U.S. Renal Care Celebrates Back-to-Back Workplace Honors

Updated Category News Views 150

U.S. Renal Care's Achievement in Workplace Excellence In a significant accomplishment for U.S. Renal Care, the company has been honored once again by Newsweek as one of America's Greatest Workplaces. This recognition highlights the organization’s dedication to creating an empowering and supportive environment for its employees, particularly in the healthcare sector. For...

Continue Reading
Unveiling the Finalists of the ServiceTitan Elite Trades Championship

Updated Category News Views 260

ServiceTitan Elite Trades Championship Series Finalists Announced The highly anticipated ServiceTitan Elite Trades Championship Series (ETCS) is ready to unveil the talented individuals who will compete in the upcoming finals. These competitors have worked hard to secure their places and are set to demonstrate their skills, precision, and expertise in the trades sector....

Continue Reading
Bekaert's Successful Share Buyback and Liquidity Update

Updated Category News Views 282

Update on Bekaert's Latest Share Buyback Program In an exciting development, Bekaert has announced significant progress regarding its share buyback program. They have allocated a maximum budget of €25 million for the current tranche, a strategic decision that's aimed at retiring shares in circulation to enhance value for shareholders. Recent Share Acquisition Details...

Continue Reading